Effects of Maternal Sildenafil Treatment on Vascular Function in Growth-Restricted Fetal Sheep
Authors:
- 1 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (4) , 731-740
Abstract
Objective—: The objective of this study was to investigate the effect of intravenous maternal sildenafil citrate (SC) administration on vascular function in growth-restricted fetal sheep. Approach and Results—: Fetal growth restriction (FGR) results in cardiovascular adaptations that redistribute cardiac output to optimize suboptimal intrauterine conditions. These adaptations result in structural and functional cardiovascular changes, which may underlie postnatal neurological and cardiovascular sequelae. Evidence suggests SC, a potent vasodilator, may improve FGR. In contrast, recent clinical evidence suggests potential for adverse fetal consequence. Currently, there is limited data on SC effects in the developing fetus. We hypothesized that SC in utero would improve vascular development and function in an ovine model of FGR. Preterm lambs (0.6 gestation) underwent sterile surgery for single umbilical artery ligation or sham (control, appropriately grown) surgery to replicate FGR. Ewes received continuous intravenous SC (36 mg/24 h) or saline from surgery until 0.83 gestation. Fetuses were delivered and immediately euthanized for collection of femoral and middle cerebral artery vessels. Vessel function was assessed via in vitro wire myography. SC exacerbated growth restriction in growth-restricted fetuses and resulted in endothelial dysfunction in the cerebral and femoral vasculature, irrespective of growth status. Dysfunction in the cerebral circulation is endothelial, whereas smooth muscle in the periphery is the origin of the deficit. Conclusions—: SC crosses the placenta and alters key fetal vascular development. Extensive studies are required to investigate the effects of SC on fetal development to address safety before additional use of SC as a treatment.Keywords
This publication has 51 references indexed in Scilit:
- Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular PhenotypePLOS ONE, 2013
- Sildenafil Promotes Smooth Muscle Preservation and Ameliorates Fibrosis Through Modulation of Extracellular Matrix and Tissue Growth Factor Gene Expression After Bilateral Cavernosal Nerve Resection in the RatThe Journal of Sexual Medicine, 2011
- Antioxidant Treatment Alters Peripheral Vascular Dysfunction Induced by Postnatal Glucocorticoid Therapy in RatsPLOS ONE, 2010
- Sildenafil Citrate Treatment Enhances Amino Acid Availability in the Conceptus and Fetal Growth in an Ovine Model of Intrauterine Growth RestrictionThe Journal of Nutrition, 2010
- Effects and mechanisms of action of sildenafil citrate in human chorionic arteriesReproductive Biology and Endocrinology, 2009
- Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxiaAmerican Journal of Obstetrics and Gynecology, 2008
- Sildenafil Citrate and Fetal Outcome in Pregnant RatsFetal Diagnosis and Therapy, 2006
- Effects of Phosphodiesterase 5 Inhibitor on Pulmonary Vascular Reactivity in the Fetal LambThe Annals of Thoracic Surgery, 2006
- Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilationThe Journal of Pediatrics, 1989
- EFFECTS OF SINGLE UMBILICAL ARTERY LIGATION IN THE LAMB FETUSObstetrical & Gynecological Survey, 1969